Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2018211544
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018211544
Title / Product Name
USPA2-PROTEINKONSTRUKTE UND VERWENDUNGEN DAVON
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2018211544
EP Publication Number
3498292
E-Number
1439371
Language
EN
PCT Number
Publication Date
19.06.2019 A
20.10.2021 B1
Registration Date
20.10.2021
AT Publication Date
15.11.2021
Application Date
20.02.2015
Registration Number
-
Priorities
24.02.2014
US
201461943909 P
30.03.2014
US
201461946932 P
03.03.2014
US
201461946937 P
IPC
A61K 39/00 20060101AFI20190314BHEP
Maximum Duration of Protection
20.02.2035
Owner
GlaxoSmithKline Biologicals SA
Rue de l'Institut, 89
1330 Rixensart
BE
Representative
Representative
SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien
AT
Inventor
BLAIS, Normand
GlaxoSmithKline Biologicals SA Rue de l'Institut 89
1330 Rixensart
BE
CASTADO, Cindy
c/o GlaxoSmithKline Biologicals SA Rue de l'Institut 89
1330 Rixensart
BE
CHOMEZ, Patrick
c/o GlaxoSmithKline Biologicals SA Rue de l'Institut 89
1330 Rixensart
BE
DEWERCHIN, Marianne
c/o GlaxoSmithKline Biologicals SA Rue de l'Institut 89
1330 Rixensart
BE